ASN Glomerular Diseases Update — Complete Guide 2025

Overview

• The ASN Glomerular Diseases Update 2025 is a comprehensive early program designed for nephrologists seeking the latest clinical insights into glomerular pathology and treatment strategies. Held in conjunction with ASN Kidney Week, this full-day course serves as a centralized update on evolving approaches to glomerulonephritis, nephritis management, and renal biopsy interpretation.
• Chaired by Dr. Rupali S. Avasare and Dr. John Cijiang He, the program features leading experts delivering evidence-based updates that translate directly into clinical practice.
• With rapid advances in targeted therapies and diagnostic technologies, clinicians must continuously adapt their approach to patient care. This course delivers practical guidance on treatment selection, disease classification, and precision diagnostics that directly impact clinical decision-making.

What You Will Learn

Advances in IgA Nephropathy Treatment

Led by Dr. Richard A. Lafayette, this module explores modern therapeutic pathways for glomerulonephritis, including newly approved pharmacologic options. Participants learn how to match treatment strategies to patient profiles and disease severity.

Updated Lupus Nephritis Management

Dr. Samir V. Parikh reviews recent guideline-driven changes affecting nephritis management strategies, helping clinicians understand therapy sequencing, add-on treatment timing, and outcome monitoring.

ANCA-Associated Vasculitis Insights

• Dr. Duvuru Geetha discusses current and emerging approaches to vasculitis care, providing clarity on evolving standards and future therapeutic directions.
• Complement Pathway Targeting
• Dr. Joshua M. Thurman presents advances in complement-based therapies and their role in treating glomerular diseases.
• Genetics in Diagnosis & Therapy
• Dr. Benjamin Wooden explains how genetic testing influences diagnosis, risk stratification, and therapeutic planning in modern nephrology.
• Monoclonal Gammopathy of Renal Significance
• Dr. Nelson Leung reviews current diagnostic and treatment considerations for MGRS and its clinical implications.
• Artificial Intelligence in Renal Biopsy Analysis
• Dr. Laura H. Mariani explores the integration of AI into renal biopsy interpretation and prognosis prediction.
• Podocytopathy & Antibody Discovery
• Dr. Kristin Meliambro presents emerging concepts in antibody-mediated disease classification and molecular diagnostics.

Clinical Application & Practice Integration

The course emphasizes real-world translation through interactive discussions and case-based learning. Clinicians gain experience in:

• Interpretation of renal biopsy findings

• Evidence-based glomerulonephritis treatment selection

• Genetic-informed decision-making

• Complex nephritis management strategies

The program also features clinicopathologic conferences that strengthen diagnostic reasoning and clinical judgment.

Who Should Enroll

This course is ideal for:

• Practicing nephrologists

• Renal fellows

• Nephropathologists

• Clinicians interpreting renal biopsy data

Why This Course Matters

Glomerular diseases are among the most complex areas of nephrology. Advances in immunotherapy, complement inhibition, and precision diagnostics require continuous education.

This program provides:

• Expert-led clinical updates

• Practical diagnostic frameworks

• Insight into emerging technologies

• Enhanced treatment decision confidence

By integrating research insights with clinical application, participants strengthen their ability to manage complex kidney disease cases effectively.